Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
|
|
NRX Pharmaceuticals, Inc. (NRXP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/17/2020 |
8-K
| Acquisition/merger/asset purchase announced|
Docs:
|
"MERGER AGREEMENT",
"BIG ROCK PARTNERS ACQUISITION CORP. ANNOUNCES MERGER WITH NEURORX, INC. COMBINED COMPANY TO HAVE AN ESTIMATED POST-TRANSACTION EQUITY VALUE IN EXCESS OF $500 MILLION , ASSUMING A SHARE PRICE OF AT LEAST $10.00 PER SHARE NeuroRx, Inc. is a clinical stage, small molecule pharmaceutical company which develops novel therapeutics for the treatment of COVID-19 ”) and Bipolar Depression Delray Beach, FL – December 14, 2020 – Big Rock Partners Acquisition Corp. , a special purpose acquisition company, announces that it has entered into an Agreement and Plan of Merger with NeuroRx, Inc. , a clinical stage, small molecule pharmaceutical company. NeuroRx develops novel therapeutics for the treatment of COVID-19 ”) and Bipolar Depression . Under the terms of the transaction, Big Rock and...",
"Investor Presentation" |
|
|
|